Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2015 Nov 21;71(Pt 12):o979–o980. doi: 10.1107/S2056989015021957

Crystal structure of 2-(4-meth­oxy­phen­yl)-6-nitro­imidazo[1,2-a]pyridine-3-carbaldehyde

Mohamed Koudad a,b, Abdelmalik Elaatiaoui a,b,*, Noureddine Benchat a, Mohamed Saadi c, Lahcen El Ammari c
PMCID: PMC4719933  PMID: 26870561

Abstract

In the title compound, C15H11N3O4, the imidazo[1,2-a] pyridine ring system is almost planar [r.m.s. deviation = 0.028 (2) Å]. Its mean plane makes dihedral angles of 33.92 (7) and 34.56 (6)° with the meth­oxy­phenyl ring and the nitro group, respectively. The cohesion of the crystal structure is ensured by C—H⋯N and C—H⋯O hydrogen bonds, forming layers almost parallel to the ac plane.

Keywords: crystal structure; imidazo[1,2-a]pyridine; carbaldehyde; hydrogen bonding

Related literature  

For biological activities of derivatives of the title compound, see: Rupert et al. (2003); Hranjec et al. (2007); Hamdouchi et al. (1999); Rival et al. (1992); Scribner et al. (2008); Bode et al. (2011). For the synthesis of similar compounds, see: Sumalatha et al. (2009); Elaatiaoui et al. (2014, 2015).graphic file with name e-71-0o979-scheme1.jpg

Experimental  

Crystal data  

  • C15H11N3O4

  • M r = 297.27

  • Monoclinic, Inline graphic

  • a = 10.8516 (6) Å

  • b = 12.0710 (6) Å

  • c = 10.2631 (5) Å

  • β = 93.200 (2)°

  • V = 1342.26 (12) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.11 mm−1

  • T = 296 K

  • 0.42 × 0.31 × 0.26 mm

Data collection  

  • Bruker X8 APEX diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2009) T min = 0.673, T max = 0.746

  • 25892 measured reflections

  • 3472 independent reflections

  • 2139 reflections with I > 2σ(I)

  • R int = 0.060

Refinement  

  • R[F 2 > 2σ(F 2)] = 0.044

  • wR(F 2) = 0.120

  • S = 1.02

  • 3472 reflections

  • 200 parameters

  • H-atom parameters constrained

  • Δρmax = 0.21 e Å−3

  • Δρmin = −0.16 e Å−3

Data collection: APEX2 (Bruker, 2009); cell refinement: SAINT (Bruker, 2009); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015021957/su5244sup1.cif

e-71-0o979-sup1.cif (940KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015021957/su5244Isup2.hkl

e-71-0o979-Isup2.hkl (277.2KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015021957/su5244Isup3.cml

. DOI: 10.1107/S2056989015021957/su5244fig1.tif

A view of the mol­ecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

. DOI: 10.1107/S2056989015021957/su5244fig2.tif

A partial view of the crystal packing of the title compound, showing mol­ecules linked by hydrogen bonds (dashed lines; Table 1), forming layers parallel to (101).

CCDC reference: 1437519

Additional supporting information: crystallographic information; 3D view; checkCIF report

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
C4—H4⋯N3i 0.93 2.53 3.412 (2) 158
C15—H15A⋯O3ii 0.96 2.52 3.423 (2) 158
C14—H14⋯O1iii 0.93 2.50 3.425 (2) 177

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic.

Acknowledgments

The authors thank the Unit of Support for Technical and Scientific Research (UATRS, CNRST) for the X-ray measurements.

supplementary crystallographic information

S1. Structural commentary

Imidazo[1,2-a]pyridines are a very inter­esting class of heterocyclic compounds because of their wide use in medicinal chemistry for the production of various pharmacologically active agents. In addition, various derivatives of imidazo[1,2-a]pyridine show a wide range of biological activities such as anti-inflammatory (Rupert et al., 2003), anti­tumor (Hranjec et al., 2007), anti­viral (Hamdouchi et al., 1999), anti­bacterial (Rival et al., 1992), anti­parasitic (Scribner et al., 2008) and anti-HIV (Bode et al., 2011). The access to the imidazo[1,2-a]pyridine scaffold is generally made by condensation of 2-amino­pyridine with a specifically chosen α-halo ketone (Sumalatha et al., 2009). The present paper is a continuation of our research devoted to the development of imidazo[1,2-a]pyridines derivatives with potential pharmacological activities (Elaatiaoui et al., 2014;2015).

In the title compound, Fig. 1, the fused five- and six-membered rings of the imidazo[1,2-a]pyridine moiety are virtually coplanar, with a maximum deviation of 0.028 (2) Å for atom C3. Its mean plane makes dihedral angles of 33.92 (7) and 34.56 (6)° with the meth­oxy­phenyl ring and the nitro group, respectively.

In the crystal, molecules are linked by C4–H4···N3, C15–H15A···O3 and C14–H14···O1 hydrogen bonds (Table 1), building layers parallel to (101), as shown in Fig. 2.

S2. Synthesis and crystallization

Phospho­rus oxychloride (3.06 g, 0.02 mol) was added to a solution of 2-(4-meth­oxy­phenyl)-5-nitro­imidazo[1,2-a]pyridine (2.69 g, 0.01 mol) in DMF (25 ml) at room temperature under stirring. The mixture was heated to 353 K for 5 h. The resulting solution was evaporated to dryness in vacuo, and the residue was treated with cold water, filtered, and crystallized from methanol to give pure product (yield 74%, Rf = 0.45 (silica, CH2Cl2/MeOH, 9/1).

Spectral data: 1H NMR (300 MHz, DMSO, δ(p.p.m.)): 10.40 (s, 1H, C5H); 10.09 (s, 1H, CH=O); 8.36 (dd, 1H, C7H, J=2.4 Hz); 7.96 (m, 3H,C8H, CphH, CphH, J= 28.2 Hz); 7.10 (d, 2H, CphH, CphH, J=9 Hz); 3.83 (s, 3H, OCH3). 13C NMR (75 MHz, DMSO) δ(p.p.m.): 180.84; 161.64; 158.81; 147.76; 138.75; 131.75; 128.32; 125.06; 124.05; 121.11; 117.04; 115.02; 55.87. m/z (M+1): 298.09.

S3. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 1. H atoms were located in a difference Fourier map and treated as riding: C–H = 0.93-0.96 Å with Uiso(H) = 1.5 Ueq for methyl H atoms and 1.2 Ueq for other H atoms. The reflection (100) affected by the beam-stop was removed during refinement.

Figures

Fig. 1.

Fig. 1.

A view of the molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

Fig. 2.

Fig. 2.

A partial view of the crystal packing of the title compound, showing molecules linked by hydrogen bonds (dashed lines; Table 1), forming layers parallel to (101).

Crystal data

C15H11N3O4 F(000) = 616
Mr = 297.27 Dx = 1.471 Mg m3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
a = 10.8516 (6) Å Cell parameters from 3472 reflections
b = 12.0710 (6) Å θ = 2.5–28.7°
c = 10.2631 (5) Å µ = 0.11 mm1
β = 93.200 (2)° T = 296 K
V = 1342.26 (12) Å3 Block, colourless
Z = 4 0.42 × 0.31 × 0.26 mm

Data collection

Bruker X8 APEX diffractometer 3472 independent reflections
Radiation source: fine-focus sealed tube 2139 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.060
φ and ω scans θmax = 28.7°, θmin = 2.5°
Absorption correction: multi-scan (SADABS; Bruker, 2009) h = −14→14
Tmin = 0.673, Tmax = 0.746 k = −16→16
25892 measured reflections l = −13→10

Refinement

Refinement on F2 Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.044 w = 1/[σ2(Fo2) + (0.0468P)2 + 0.3011P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.120 (Δ/σ)max < 0.001
S = 1.02 Δρmax = 0.21 e Å3
3472 reflections Δρmin = −0.16 e Å3
200 parameters Extinction correction: SHELXL2014 (Sheldrick, 2015), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 restraints Extinction coefficient: 0.0038 (11)

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C1 −0.02574 (15) 0.14080 (13) 0.14955 (15) 0.0384 (4)
H1 −0.0116 0.0650 0.1559 0.046*
C2 −0.11433 (16) 0.19026 (13) 0.21703 (15) 0.0396 (4)
C3 −0.13789 (17) 0.30501 (14) 0.21067 (18) 0.0479 (4)
H3 −0.1979 0.3366 0.2601 0.057*
C4 −0.07141 (17) 0.36854 (14) 0.13112 (18) 0.0479 (4)
H4 −0.0867 0.4442 0.1242 0.058*
C5 0.02062 (16) 0.31952 (12) 0.05933 (16) 0.0397 (4)
C6 0.14059 (15) 0.18113 (12) −0.00409 (15) 0.0369 (4)
C7 0.20276 (17) 0.07630 (13) 0.00131 (16) 0.0423 (4)
H7 0.2746 0.0694 −0.0433 0.051*
C8 0.17220 (16) 0.28204 (13) −0.05971 (15) 0.0377 (4)
C9 0.27357 (16) 0.30700 (13) −0.14343 (15) 0.0389 (4)
C10 0.33469 (18) 0.40926 (14) −0.12918 (18) 0.0490 (5)
H10 0.3104 0.4595 −0.0668 0.059*
C11 0.42963 (19) 0.43593 (15) −0.20600 (19) 0.0547 (5)
H11 0.4698 0.5036 −0.1945 0.066*
C12 0.46660 (17) 0.36275 (15) −0.30113 (17) 0.0467 (4)
C13 0.40815 (17) 0.26118 (14) −0.31569 (16) 0.0435 (4)
H13 0.4330 0.2111 −0.3779 0.052*
C14 0.31262 (17) 0.23437 (13) −0.23732 (16) 0.0422 (4)
H14 0.2738 0.1660 −0.2479 0.051*
C15 0.5928 (2) 0.32902 (19) −0.4794 (2) 0.0685 (6)
H15A 0.6582 0.3633 −0.5241 0.103*
H15B 0.6204 0.2588 −0.4449 0.103*
H15C 0.5228 0.3180 −0.5394 0.103*
N1 −0.18828 (14) 0.11943 (13) 0.29732 (14) 0.0482 (4)
N2 0.04176 (12) 0.20585 (10) 0.07215 (12) 0.0356 (3)
N3 0.09779 (14) 0.36523 (11) −0.02137 (14) 0.0438 (4)
O1 −0.17708 (14) 0.01936 (11) 0.28788 (14) 0.0623 (4)
O2 −0.25834 (15) 0.16393 (13) 0.37021 (15) 0.0741 (5)
O3 0.16791 (13) −0.00450 (9) 0.06039 (13) 0.0548 (4)
O4 0.55866 (13) 0.39871 (12) −0.37535 (13) 0.0631 (4)

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C1 0.0429 (9) 0.0298 (7) 0.0421 (9) −0.0019 (7) −0.0011 (8) 0.0014 (7)
C2 0.0425 (10) 0.0377 (8) 0.0385 (9) −0.0045 (7) 0.0019 (8) −0.0010 (7)
C3 0.0515 (11) 0.0395 (9) 0.0532 (11) 0.0025 (8) 0.0086 (9) −0.0072 (8)
C4 0.0546 (11) 0.0304 (8) 0.0594 (11) 0.0055 (8) 0.0083 (9) −0.0021 (8)
C5 0.0467 (10) 0.0270 (7) 0.0448 (9) 0.0014 (7) −0.0011 (8) 0.0011 (7)
C6 0.0396 (9) 0.0325 (8) 0.0385 (8) −0.0008 (7) 0.0011 (7) −0.0006 (7)
C7 0.0463 (10) 0.0350 (8) 0.0456 (10) 0.0034 (7) 0.0036 (8) 0.0010 (7)
C8 0.0432 (9) 0.0326 (8) 0.0370 (8) 0.0001 (7) −0.0026 (7) 0.0012 (6)
C9 0.0436 (9) 0.0351 (8) 0.0378 (9) −0.0004 (7) −0.0009 (7) 0.0040 (7)
C10 0.0588 (12) 0.0380 (9) 0.0506 (10) −0.0050 (8) 0.0070 (9) −0.0049 (8)
C11 0.0641 (13) 0.0406 (9) 0.0603 (12) −0.0170 (9) 0.0103 (10) −0.0053 (8)
C12 0.0479 (10) 0.0484 (10) 0.0441 (10) −0.0087 (8) 0.0035 (8) 0.0026 (8)
C13 0.0490 (11) 0.0428 (9) 0.0386 (9) −0.0031 (8) 0.0015 (8) −0.0022 (7)
C14 0.0504 (11) 0.0342 (8) 0.0418 (9) −0.0074 (7) −0.0004 (8) 0.0010 (7)
C15 0.0619 (14) 0.0834 (16) 0.0622 (13) −0.0196 (12) 0.0228 (11) −0.0136 (11)
N1 0.0485 (9) 0.0496 (9) 0.0465 (8) −0.0048 (7) 0.0042 (7) 0.0000 (7)
N2 0.0399 (8) 0.0277 (6) 0.0388 (7) 0.0004 (5) −0.0002 (6) 0.0000 (5)
N3 0.0514 (9) 0.0316 (7) 0.0487 (8) 0.0017 (6) 0.0044 (7) 0.0039 (6)
O1 0.0686 (10) 0.0432 (7) 0.0765 (10) −0.0044 (6) 0.0153 (8) 0.0124 (7)
O2 0.0803 (11) 0.0707 (10) 0.0752 (10) −0.0053 (8) 0.0386 (9) −0.0078 (8)
O3 0.0638 (9) 0.0343 (6) 0.0676 (8) 0.0080 (6) 0.0155 (7) 0.0104 (6)
O4 0.0654 (9) 0.0664 (9) 0.0593 (8) −0.0241 (7) 0.0201 (7) −0.0072 (7)

Geometric parameters (Å, º)

C1—C2 1.354 (2) C9—C14 1.386 (2)
C1—N2 1.360 (2) C9—C10 1.405 (2)
C1—H1 0.9300 C10—C11 1.370 (3)
C2—C3 1.409 (2) C10—H10 0.9300
C2—N1 1.459 (2) C11—C12 1.392 (3)
C3—C4 1.357 (2) C11—H11 0.9300
C3—H3 0.9300 C12—O4 1.361 (2)
C4—C5 1.405 (2) C12—C13 1.385 (2)
C4—H4 0.9300 C13—C14 1.385 (2)
C5—N3 1.330 (2) C13—H13 0.9300
C5—N2 1.3961 (19) C14—H14 0.9300
C6—N2 1.395 (2) C15—O4 1.424 (2)
C6—C8 1.396 (2) C15—H15A 0.9600
C6—C7 1.434 (2) C15—H15B 0.9600
C7—O3 1.2197 (19) C15—H15C 0.9600
C7—H7 0.9300 N1—O1 1.2184 (19)
C8—N3 1.360 (2) N1—O2 1.220 (2)
C8—C9 1.464 (2)
C2—C1—N2 117.71 (14) C11—C10—H10 119.6
C2—C1—H1 121.1 C9—C10—H10 119.6
N2—C1—H1 121.1 C10—C11—C12 120.65 (17)
C1—C2—C3 122.79 (16) C10—C11—H11 119.7
C1—C2—N1 117.32 (15) C12—C11—H11 119.7
C3—C2—N1 119.88 (16) O4—C12—C13 124.62 (17)
C4—C3—C2 118.83 (16) O4—C12—C11 116.07 (16)
C4—C3—H3 120.6 C13—C12—C11 119.30 (17)
C2—C3—H3 120.6 C12—C13—C14 119.81 (16)
C3—C4—C5 119.67 (16) C12—C13—H13 120.1
C3—C4—H4 120.2 C14—C13—H13 120.1
C5—C4—H4 120.2 C13—C14—C9 121.56 (15)
N3—C5—N2 111.14 (14) C13—C14—H14 119.2
N3—C5—C4 129.99 (15) C9—C14—H14 119.2
N2—C5—C4 118.85 (15) O4—C15—H15A 109.5
N2—C6—C8 104.88 (13) O4—C15—H15B 109.5
N2—C6—C7 122.83 (14) H15A—C15—H15B 109.5
C8—C6—C7 131.31 (16) O4—C15—H15C 109.5
O3—C7—C6 124.53 (17) H15A—C15—H15C 109.5
O3—C7—H7 117.7 H15B—C15—H15C 109.5
C6—C7—H7 117.7 O1—N1—O2 123.60 (16)
N3—C8—C6 111.25 (15) O1—N1—C2 118.41 (15)
N3—C8—C9 119.68 (14) O2—N1—C2 118.00 (15)
C6—C8—C9 128.98 (15) C1—N2—C6 131.33 (13)
C14—C9—C10 117.84 (16) C1—N2—C5 122.11 (14)
C14—C9—C8 123.12 (15) C6—N2—C5 106.55 (13)
C10—C9—C8 119.04 (15) C5—N3—C8 106.16 (13)
C11—C10—C9 120.81 (17) C12—O4—C15 117.45 (15)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C4—H4···N3i 0.93 2.53 3.412 (2) 158
C15—H15A···O3ii 0.96 2.52 3.423 (2) 158
C14—H14···O1iii 0.93 2.50 3.425 (2) 177

Symmetry codes: (i) −x, −y+1, −z; (ii) −x+1, y+1/2, −z−1/2; (iii) −x, −y, −z.

Footnotes

Supporting information for this paper is available from the IUCr electronic archives (Reference: SU5244).

References

  1. Bode, M. L., Gravestock, D., Moleele, S. S., van der Westhuyzen, C. W., Pelly, S. C., Steenkamp, P. A., Hoppe, H. C., Khan, T. & Nkabinde, L. A. (2011). Bioorg. Med. Chem. 19, 4227–4237. [DOI] [PubMed]
  2. Bruker (2009). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
  3. Elaatiaoui, A., Koudad, M., Saddik, R., Benchat, N. & El Ammari, L. (2014). Acta Cryst. E70, o1189–o1190. [DOI] [PMC free article] [PubMed]
  4. Elaatiaoui, A., Saddik, R., Benchat, N., Saadi, M. & El Ammari, L. (2015). Acta Cryst. E71, o803–o804. [DOI] [PMC free article] [PubMed]
  5. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
  6. Hamdouchi, C., de Blas, J., del Prado, M., Gruber, J., Heinz, B. A. & Vance, L. (1999). J. Med. Chem. 42, 50–59. [DOI] [PubMed]
  7. Hranjec, M., Kralj, M., Piantanida, I., Sedić, M., Šuman, L., Pavelić, K. & Karminski-Zamola, G. (2007). J. Med. Chem. 50, 5696–5711. [DOI] [PubMed]
  8. Rival, Y., Grassy, G. & Michel, G. (1992). Chem. Pharm. Bull. 40, 1170–1176. [DOI] [PubMed]
  9. Rupert, K. C., Henry, J. R., Dodd, J. H., Wadsworth, S. A., Cavender, D. E., Olini, G. C., Fahmy, B. & Siekierka, J. J. (2003). Bioorg. Med. Chem. Lett. 13, 347–350. [DOI] [PubMed]
  10. Scribner, A., Dennis, R., Lee, S., Ouvry, G., Perrey, D., Fisher, M., Wyvratt, M., Leavitt, P., Liberator, P., Gurnett, A., Brown, C., Mathew, J., Thompson, D., Schmatz, D. & Biftu, T. (2008). Eur. J. Med. Chem. 43, 1123–1151. [DOI] [PubMed]
  11. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  12. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  13. Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
  14. Sumalatha, Y., Reddy, T. R., Reddy, P. P. & Satyanarayana, B. (2009). Arkivoc, pp. 315–320.
  15. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015021957/su5244sup1.cif

e-71-0o979-sup1.cif (940KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015021957/su5244Isup2.hkl

e-71-0o979-Isup2.hkl (277.2KB, hkl)

Supporting information file. DOI: 10.1107/S2056989015021957/su5244Isup3.cml

. DOI: 10.1107/S2056989015021957/su5244fig1.tif

A view of the mol­ecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

. DOI: 10.1107/S2056989015021957/su5244fig2.tif

A partial view of the crystal packing of the title compound, showing mol­ecules linked by hydrogen bonds (dashed lines; Table 1), forming layers parallel to (101).

CCDC reference: 1437519

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES